These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 827023)

  • 21. Tumour markers in ovarian cancer.
    van Nagell JR
    Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
    [No Abstract]   [Full Text] [Related]  

  • 22. Ovarian tumor-specific antigens.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1974 Aug; 119(7):966-70. PubMed ID: 4135399
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
    Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
    Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
    Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
    Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The present status of tumor markers in malignant ovarian tumor].
    Nishimura H; Miyoshi T; Hamai J; Miyahara K
    Gan No Rinsho; 1985 May; 31(6 Suppl):589-93. PubMed ID: 2411960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigens.
    Smith LH; Oi RH
    Obstet Gynecol Surv; 1984 Jun; 39(6):346-60. PubMed ID: 6203071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common antigenic component in ovarian carcinomas: demonstration by double diffusion and immunofluorescence techniques.
    Dorsett BH; Ioachim HL
    Immunol Commun; 1973; 2(2):173-84. PubMed ID: 4125449
    [No Abstract]   [Full Text] [Related]  

  • 30. The immune system in gynecologic malignancies.
    Barber HR; Dorsett B
    Prog Clin Biol Res; 1981; 70():357-69. PubMed ID: 6171833
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitation of antigens in normal and malignant ovarian tissue.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1975 Oct; 123(3):302-4. PubMed ID: 1180293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical usefulness of tumor markers for the diagnosis of ovarian cancer].
    Ito K; Udagawa Y; Nozawa S
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1964-70. PubMed ID: 1417005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
    Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
    Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte migration in ovarian carcinoma: comparison of inhibitory activity of tumor extracts.
    Faiferman I; Gleicher N; Cohen CJ; Koffler D
    J Natl Cancer Inst; 1977 Dec; 59(6):1593-7. PubMed ID: 200754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mucinous carcinoma-associated antigen (MCA) in ovarian cancer].
    Hanzal E; Kölbl H; Gitsch G; Bieglmayer C
    Gynakol Rundsch; 1990; 30 Suppl 1():68-70. PubMed ID: 2079303
    [No Abstract]   [Full Text] [Related]  

  • 37. Ovarian tumor antigens: preliminary histological investigation.
    Daunter B; Jaa-Kwee D; Miklosi S; Wright G
    Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation, immunological characterization, and structural studies of a tumor antigen related to carcinoembryonic antigen.
    Kessler MJ; Shively JE; Pritchard DG; Todd CW
    Cancer Res; 1978 Apr; 38(4):1041-8. PubMed ID: 205343
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor antigens in ovarian malignancy.
    Rubin SC; Lewis JL
    Clin Obstet Gynecol; 1986 Sep; 29(3):693-704. PubMed ID: 2428553
    [No Abstract]   [Full Text] [Related]  

  • 40. [Tumor markers in epithelial ovarian cancer].
    Di Cocco B; Calabretta F; Alghisi F; Salesi N; Bossone G
    Minerva Ginecol; 2003 Aug; 55(4):327-32. PubMed ID: 14581857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.